BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17923786)

  • 1. The role of PET/CT for evaluating breast cancer.
    Yang SK; Cho N; Moon WK
    Korean J Radiol; 2007; 8(5):429-37. PubMed ID: 17923786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
    Jung NY; Yoo IR; Kang BJ; Kim SH; Chae BJ; Seo YY
    Breast Cancer; 2016 Jan; 23(1):141-148. PubMed ID: 24872087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of multidetector row computed tomography in patient with breast cancer.
    Kang DK; Kim MJ; Jung YS; Yim H
    J Comput Assist Tomogr; 2008; 32(4):583-98. PubMed ID: 18664847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic performance.
    Sohn YM; Hong IK; Han K
    J Ultrasound Med; 2014 Jun; 33(6):1013-21. PubMed ID: 24866608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
    Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
    Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the accuracy of
    Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
    Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation.
    Ghai S; Muradali D; Bukhanov K; Kulkarni S
    AJR Am J Roentgenol; 2005 Aug; 185(2):481-7. PubMed ID: 16037524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of Positron Emission Tomography/Computed Tomography and Ultrasound Imaging for Detection of Internal Mammary Lymph Node Metastases in Patients With Breast Cancer and Pathologic Correlation by Ultrasound-Guided Biopsy Procedures.
    An YY; Kim SH; Kang BJ; Lee AW
    J Ultrasound Med; 2015 Aug; 34(8):1385-94. PubMed ID: 26206824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
    Zhao TT; Li JG; Li YM
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
    Monzawa S; Adachi S; Suzuki K; Hirokaga K; Takao S; Sakuma T; Hanioka K
    Ann Nucl Med; 2009 Dec; 23(10):855-61. PubMed ID: 19876704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X; Wu F; Han P
    Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
    Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Botsikas D; Bagetakos I; Picarra M; Da Cunha Afonso Barisits AC; Boudabbous S; Montet X; Lam GT; Mainta I; Kalovidouri A; Becker M
    Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
    Orevi M; Freedman N; Tahover E; Uziely B; Chisin R; Peretz T; Klein M
    Acta Oncol; 2016; 55(2):244-7. PubMed ID: 26106853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.